(Q83169475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Ewing sarcoma/PNET: 27 years of experience in Slovenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Ziva Pohar Marinsek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Rajko Kavalar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Berta Jereb

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Hematology and Oncology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

355-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

Redefined role of radiation in combined treatment of Ewing's sarcoma

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Ewing sarcoma: the pediatrician's point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Treatment of Ewing sarcoma family of tumors: current status and outlook for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Surgical indications for Ewing's sarcoma of the pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Treatment results and prognostic factors in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Complications in long-term survivors of Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Ewing's sarcoma: Ten-year experience with adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Adult Soft Tissue Ewing Sarcoma or Primitive Neuroectodermal Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010600632001

10.1080/08880010600632001

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16621778%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference